Journal of Evidence-Based Dental Practice
Volume 4, Issue 1 , Pages 32-36 , March 2004

Levels of Clinical Significance

References 

  1. Slade GD, Spencer AJ. Development and evaluation of the Oral Health Impact Profile. Community Dent Health. 1994;11(1):3–11
  2. McGrath C, Bedi R. An evaluation of a new measure of oral health related quality of life–OHQoL-UK(W). Community Dent Health. 2001;18(3):138–143
  3. Leao A, Sheiham A. The development of a socio-dental measure of dental impacts on daily living. Community Dent Health. 1996;13(1):22–26
  4. Report of the Committee of Principal Investigators . WHO cooperative trial on primary prevention of ischaemic heart disease with clofibrate to lower serum cholesterol: final mortality follow-up. Lancet. 1984;2(8043):600–604
  5. D Haguenauer, V Welch, B Shea, P Tugwell, G Wells, Fluoride for treating postmenopausal osteoporosis. Cochrane Database Syst Rev 2000(4):CD002825.
  6. PP Hujoel, Endpoints in periodontal trials: the need for an evidence-based research approach. Periodontol 2000 2004;In press.
  7. Awad MA, Locker D, Korner-Bitensky N, Feine JS. Measuring the effect of intra-oral implant rehabilitation on health-related quality of life in a randomized controlled clinical trial. J Dent Res. 2000;79(9):1659–1663
  8. Taubes G. Epidemiology faces its limits. Science. 1995;269(5221):164–169
  9. Feinstein AR. Scientific standards in epidemiologic studies of the menace of daily life. Science. 1988;242(4883):1257–1263
  10. Rosenfeld L. Vitamine—vitamin. The early years of discovery. Clin Chem. 1997;43(4):680–685
  11. Wade OL. Digoxin 1785-1985. I Two hundred years of digitalis. J Clin Hosp Pharm. 1986;11(1):3–9
  12. Shaldubina A, Agam G, Belmaker RH. The mechanism of lithium action: state of the art, ten years later. Prog Neuropsychopharmacol Biol Psychiatry. 2001;25(4):855–866
  13. Hogervorst E. Estrogen plus progestin use did not improve global cognitive function in older postmenopausal women. Evidence-based obstetrics and gynecology. 2003;5:189–191
  14. Berwick DM. Disseminating innovations in health care. JAMA. 2003;289(15):1969–1975
  15. Roddis LH. A short history of nautical medicine. New York: P B Hoeber Inc; 1941;
  16. An international randomized trial comparing four thrombolytic strategies for acute myocardial infarction . The GUSTO investigators. N Engl J Med. 1993;329(10):673–682
  17. Raborn GW, Martel AY, Lassonde M, Lewis MA, Boon R, Spruance SL. Effective treatment of herpes simplex labialis with penciclovir cream: combined results of two trials. J Am Dent Assoc. 2002;133(3):303–309
  18. Mocroft A, Ledergerber B, Katlama C, Kirk O, Reiss P, d'Arminio Monforte A, et al.  Decline in the AIDS and death rates in the EuroSIDA study: an observational study. Lancet. 2003;362(9377):22–29
  19. O'Brien SG, Deininger MW. Imatinib in patients with newly diagnosed chronic-phase chronic myeloid leukemia. Semin Hematol. 2003;40(2 Suppl 3):26–30
  20. Sandham HJ, Brown J, Chan KH, Phillips HI, Burgess RC, Stokl AJ. Clinical trial in adults of an antimicrobial varnish for reducing mutans streptococci. J Dent Res. 1991;70(11):1401–1408
  21. Fleming TR, Prentice RL, Pepe MS, Glidden D. Surrogate and auxiliary endpoints in clinical trials, with potential applications in cancer and AIDS research. Stat Med. 1994;13(9):955–968
  22. Forgie AH, Paterson M, Pine CM, Pitts NB, Nugent ZJ. A randomised controlled trial of the caries-preventive efficacy of a chlorhexidine-containing varnish in high-caries-risk adolescents. Caries Res. 2000;34(5):432–439
  23. Berkowitz D. Long-term treatment of hyperlipidemic patients with clofibrate. JAMA. 1971;218(7):1002–1005
  24. Psaty BM, Weiss NS, Furberg CD, Koepsell TD, Siscovick DS, Rosendaal FR, et al.  Surrogate end points, health outcomes, and the drug-approval process for the treatment of risk factors for cardiovascular disease. JAMA. 1999;282(8):786–790

PII: S1532-3382(04)00013-2

doi: 10.1016/j.jebdp.2004.02.012

Journal of Evidence-Based Dental Practice
Volume 4, Issue 1 , Pages 32-36 , March 2004

Article Tools